APO Research

APO RESEARCH · REPORT

Peptide CRO Services

Selected research

Market Structure

Global Peptide CRO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Peptide CRO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Peptide CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Peptide CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptide CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Peptide CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peptide CRO Services include IMED Bioscience, Peptites Biotech, Genevoyager, Viva Biotech, Space Peptides Pharmaceutical, Motif Biotechnology, JYMed Technology, GenScript and TriApex Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Peptide CRO Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peptide CRO Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peptide CRO Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Peptide CRO Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Peptide CRO Services Segment by Company

IMED Bioscience

Peptites Biotech

Genevoyager

Viva Biotech

Space Peptides Pharmaceutical

Motif Biotechnology

JYMed Technology

GenScript

TriApex Laboratories

Go Top Peptide Biotech

Sun-Novo Pharmaceutical Research

Thermo Fisher

Syngene

Svar Life Science

PolyPeptide

PeptiSystems

Peptide Institute

Immunocure

Cusabio

CSBio

CPC Scientific

Buchi

Bachem AG

Aurigene Pharmaceutical Services

AmbioPharm

ABZENA PLC

Peptide CRO Services Segment by Type

Modified Peptide Synthesis

Linear Peptide Synthesis

Cyclic Peptide Synthesis

Others

Peptide CRO Services Segment by Application

Pharmaceutical Companies

Biological Laboratories

Others

Peptide CRO Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide CRO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide CRO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide CRO Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Peptide CRO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peptide CRO Services industry.

Chapter 3: Detailed analysis of Peptide CRO Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide CRO Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Peptide CRO Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Modified Peptide Synthesis Table 3. Key Players of Linear Peptide Synthesis Table 4. Key Players of Cyclic Peptide Synthesis Table 3. Key Players of Others Table 4. Global Peptide CRO Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Companies Table 6. Key Players of Biological Laboratories Table 7. Key Players of Others Table 8. Global Peptide CRO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Peptide CRO Services Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Peptide CRO Services Market Share by Region (2021-2026) Table 11. Global Peptide CRO Services Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Peptide CRO Services Market Share by Region (2027-2032) Table 13. Peptide CRO Services Industry Trends Table 14. Peptide CRO Services Industry Drivers Table 15. Peptide CRO Services Industry Opportunities and Challenges Table 16. Peptide CRO Services Industry Restraints Table 17. Global Peptide CRO Services Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Peptide CRO Services Revenue Market Share by Company (2021-2026) Table 19. Global Peptide CRO Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Peptide CRO Services Key Company Head Office and Area Served Table 21. Global Peptide CRO Services Company, Product Type & Application Table 22. Global Peptide CRO Services Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Peptide CRO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Peptide CRO Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Peptide CRO Services Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Peptide CRO Services Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Peptide CRO Services Revenue Market Share by Type (2021-2026) Table 29. Global Peptide CRO Services Revenue Market Share by Type (2027-2032) Table 30. Global Peptide CRO Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Peptide CRO Services Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Peptide CRO Services Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Peptide CRO Services Revenue Market Share by Application (2021-2026) Table 34. Global Peptide CRO Services Revenue Market Share by Application (2027-2032) Table 35. IMED Bioscience Company Information Table 36. IMED Bioscience Business Overview Table 37. IMED Bioscience Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. IMED Bioscience Peptide CRO Services Product Portfolio Table 39. IMED Bioscience Recent Development Table 40. Peptites Biotech Company Information Table 41. Peptites Biotech Business Overview Table 42. Peptites Biotech Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Peptites Biotech Peptide CRO Services Product Portfolio Table 44. Peptites Biotech Recent Development Table 45. Genevoyager Company Information Table 46. Genevoyager Business Overview Table 47. Genevoyager Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Genevoyager Peptide CRO Services Product Portfolio Table 49. Genevoyager Recent Development Table 50. Viva Biotech Company Information Table 51. Viva Biotech Business Overview Table 52. Viva Biotech Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Viva Biotech Peptide CRO Services Product Portfolio Table 54. Viva Biotech Recent Development Table 55. Space Peptides Pharmaceutical Company Information Table 56. Space Peptides Pharmaceutical Business Overview Table 57. Space Peptides Pharmaceutical Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Space Peptides Pharmaceutical Peptide CRO Services Product Portfolio Table 59. Space Peptides Pharmaceutical Recent Development Table 60. Motif Biotechnology Company Information Table 61. Motif Biotechnology Business Overview Table 62. Motif Biotechnology Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Motif Biotechnology Peptide CRO Services Product Portfolio Table 64. Motif Biotechnology Recent Development Table 65. JYMed Technology Company Information Table 66. JYMed Technology Business Overview Table 67. JYMed Technology Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. JYMed Technology Peptide CRO Services Product Portfolio Table 69. JYMed Technology Recent Development Table 70. GenScript Company Information Table 71. GenScript Business Overview Table 72. GenScript Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. GenScript Peptide CRO Services Product Portfolio Table 74. GenScript Recent Development Table 75. TriApex Laboratories Company Information Table 76. TriApex Laboratories Business Overview Table 77. TriApex Laboratories Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. TriApex Laboratories Peptide CRO Services Product Portfolio Table 79. TriApex Laboratories Recent Development Table 80. Go Top Peptide Biotech Company Information Table 81. Go Top Peptide Biotech Business Overview Table 82. Go Top Peptide Biotech Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Go Top Peptide Biotech Peptide CRO Services Product Portfolio Table 84. Go Top Peptide Biotech Recent Development Table 85. Sun-Novo Pharmaceutical Research Company Information Table 86. Sun-Novo Pharmaceutical Research Business Overview Table 87. Sun-Novo Pharmaceutical Research Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Sun-Novo Pharmaceutical Research Peptide CRO Services Product Portfolio Table 89. Sun-Novo Pharmaceutical Research Recent Development Table 90. Thermo Fisher Company Information Table 91. Thermo Fisher Business Overview Table 92. Thermo Fisher Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Thermo Fisher Peptide CRO Services Product Portfolio Table 94. Thermo Fisher Recent Development Table 95. Syngene Company Information Table 96. Syngene Business Overview Table 97. Syngene Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Syngene Peptide CRO Services Product Portfolio Table 99. Syngene Recent Development Table 100. Svar Life Science Company Information Table 101. Svar Life Science Business Overview Table 102. Svar Life Science Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Svar Life Science Peptide CRO Services Product Portfolio Table 104. Svar Life Science Recent Development Table 105. PolyPeptide Company Information Table 106. PolyPeptide Business Overview Table 107. PolyPeptide Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. PolyPeptide Peptide CRO Services Product Portfolio Table 109. PolyPeptide Recent Development Table 110. PeptiSystems Company Information Table 111. PeptiSystems Business Overview Table 112. PeptiSystems Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. PeptiSystems Peptide CRO Services Product Portfolio Table 114. PeptiSystems Recent Development Table 115. Peptide Institute Company Information Table 116. Peptide Institute Business Overview Table 117. Peptide Institute Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Peptide Institute Peptide CRO Services Product Portfolio Table 119. Peptide Institute Recent Development Table 120. Immunocure Company Information Table 121. Immunocure Business Overview Table 122. Immunocure Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Immunocure Peptide CRO Services Product Portfolio Table 124. Immunocure Recent Development Table 125. Cusabio Company Information Table 126. Cusabio Business Overview Table 127. Cusabio Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Cusabio Peptide CRO Services Product Portfolio Table 129. Cusabio Recent Development Table 130. CSBio Company Information Table 131. CSBio Business Overview Table 132. CSBio Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. CSBio Peptide CRO Services Product Portfolio Table 134. CSBio Recent Development Table 135. CPC Scientific Company Information Table 136. CPC Scientific Business Overview Table 137. CPC Scientific Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. CPC Scientific Peptide CRO Services Product Portfolio Table 139. CPC Scientific Recent Development Table 140. Buchi Company Information Table 141. Buchi Business Overview Table 142. Buchi Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 143. Buchi Peptide CRO Services Product Portfolio Table 144. Buchi Recent Development Table 145. Bachem AG Company Information Table 146. Bachem AG Business Overview Table 147. Bachem AG Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 148. Bachem AG Peptide CRO Services Product Portfolio Table 149. Bachem AG Recent Development Table 150. Aurigene Pharmaceutical Services Company Information Table 151. Aurigene Pharmaceutical Services Business Overview Table 152. Aurigene Pharmaceutical Services Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 153. Aurigene Pharmaceutical Services Peptide CRO Services Product Portfolio Table 154. Aurigene Pharmaceutical Services Recent Development Table 155. AmbioPharm Company Information Table 156. AmbioPharm Business Overview Table 157. AmbioPharm Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 158. AmbioPharm Peptide CRO Services Product Portfolio Table 159. AmbioPharm Recent Development Table 160. ABZENA PLC Company Information Table 161. ABZENA PLC Business Overview Table 162. ABZENA PLC Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 163. ABZENA PLC Peptide CRO Services Product Portfolio Table 164. ABZENA PLC Recent Development Table 165. North America Peptide CRO Services Market Size by Type (2021-2026) & (US$ Million) Table 166. North America Peptide CRO Services Market Size by Type (2027-2032) & (US$ Million) Table 167. North America Peptide CRO Services Market Size by Application (2021-2026) & (US$ Million) Table 168. North America Peptide CRO Services Market Size by Application (2027-2032) & (US$ Million) Table 169. North America Peptide CRO Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. North America Peptide CRO Services Market Size by Country (2021-2026) Table 171. North America Peptide CRO Services Market Size by Country (2027-2032) Table 172. Europe Peptide CRO Services Market Size by Type (2021-2026) & (US$ Million) Table 173. Europe Peptide CRO Services Market Size by Type (2027-2032) & (US$ Million) Table 174. Europe Peptide CRO Services Market Size by Application (2021-2026) & (US$ Million) Table 175. Europe Peptide CRO Services Market Size by Application (2027-2032) & (US$ Million) Table 176. Europe Peptide CRO Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Europe Peptide CRO Services Market Size by Country (2021-2026) Table 178. Europe Peptide CRO Services Market Size by Country (2027-2032) Table 179. China Peptide CRO Services Market Size by Type (2021-2026) & (US$ Million) Table 180. China Peptide CRO Services Market Size by Type (2027-2032) & (US$ Million) Table 181. China Peptide CRO Services Market Size by Application (2021-2026) & (US$ Million) Table 182. China Peptide CRO Services Market Size by Application (2027-2032) & (US$ Million) Table 183. Asia Peptide CRO Services Market Size by Type (2021-2026) & (US$ Million) Table 184. Asia Peptide CRO Services Market Size by Type (2027-2032) & (US$ Million) Table 185. Asia Peptide CRO Services Market Size by Application (2021-2026) & (US$ Million) Table 186. Asia Peptide CRO Services Market Size by Application (2027-2032) & (US$ Million) Table 187. Asia Peptide CRO Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. Asia Peptide CRO Services Market Size by Country (2021-2026) Table 189. Asia Peptide CRO Services Market Size by Country (2027-2032) Table 190. South America, Middle East & Africa Peptide CRO Services Market Size by Type (2021-2026) & (US$ Million) Table 191. South America, Middle East & Africa Peptide CRO Services Market Size by Type (2027-2032) & (US$ Million) Table 192. South America, Middle East & Africa Peptide CRO Services Market Size by Application (2021-2026) & (US$ Million) Table 193. South America, Middle East & Africa Peptide CRO Services Market Size by Application (2027-2032) & (US$ Million) Table 194. South America, Middle East & Africa Peptide CRO Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. South America, Middle East & Africa Peptide CRO Services Market Size by Country (2021-2026) Table 196. South America, Middle East & Africa Peptide CRO Services Market Size by Country (2027-2032) Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Peptide CRO Services Product Image Figure 2. Global Peptide CRO Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Peptide CRO Services Market Share by Type: 2025 VS 2032 Figure 4. Modified Peptide Synthesis Image Figure 5. Linear Peptide Synthesis Image Figure 6. Cyclic Peptide Synthesis Image Figure 7. Others Image Figure 8. Global Peptide CRO Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Peptide CRO Services Market Share by Application: 2025 VS 2032 Figure 10. Pharmaceutical Companies Image Figure 11. Biological Laboratories Image Figure 12. Others Image Figure 13. Global Peptide CRO Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 15. Global Peptide CRO Services Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Peptide CRO Services Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Peptide CRO Services Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Peptide CRO Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Peptide CRO Services Revenue Market Share by Type (2021-2032) Figure 22. Global Peptide CRO Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Peptide CRO Services Revenue Market Share by Application (2021-2032) Figure 24. North America Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 25. North America Peptide CRO Services Market Share by Type (2021-2032) Figure 26. North America Peptide CRO Services Market Share by Application (2021-2032) Figure 27. North America Peptide CRO Services Market Share by Country (2021-2032) Figure 28. United States Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 29. Canada Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 31. Europe Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 32. Europe Peptide CRO Services Market Share by Type (2021-2032) Figure 33. Europe Peptide CRO Services Market Share by Application (2021-2032) Figure 34. Europe Peptide CRO Services Market Share by Country (2021-2032) Figure 35. Germany Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 36. France Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 38. Italy Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 39. Russia Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 41. China Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 42. China Peptide CRO Services Market Share by Type (2021-2032) Figure 43. China Peptide CRO Services Market Share by Application (2021-2032) Figure 44. Asia Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 45. Asia Peptide CRO Services Market Share by Type (2021-2032) Figure 46. Asia Peptide CRO Services Market Share by Application (2021-2032) Figure 47. Asia Peptide CRO Services Market Share by Country (2021-2032) Figure 48. Japan Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 52. India Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 53. Australia Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Peptide CRO Services Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Peptide CRO Services Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Peptide CRO Services Market Share by Country (2021-2032) Figure 58. Brazil Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 63. UAE Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 65. Chile Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Modified Peptide Synthesis
  • Linear Peptide Synthesis
  • Cyclic Peptide Synthesis
  • Others
Applications
  • Pharmaceutical Companies
  • Biological Laboratories
  • Others
Companies covered
  • IMED Bioscience
  • Peptites Biotech
  • Genevoyager
  • Viva Biotech
  • Space Peptides Pharmaceutical
  • Motif Biotechnology
  • JYMed Technology
  • GenScript
  • TriApex Laboratories
  • Go Top Peptide Biotech
  • Sun-Novo Pharmaceutical Research
  • Thermo Fisher
  • Syngene
  • Svar Life Science
  • PolyPeptide
  • PeptiSystems
  • Peptide Institute
  • Immunocure
  • Cusabio
  • CSBio
  • CPC Scientific
  • Buchi
  • Bachem AG
  • Aurigene Pharmaceutical Services
  • AmbioPharm
  • ABZENA PLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Peptide CRO Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Modified Peptide Synthesis
  5. 1.2.3 Linear Peptide Synthesis
  6. 1.2.4 Cyclic Peptide Synthesis
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Peptide CRO Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Companies
  11. 1.3.3 Biological Laboratories
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Peptide CRO Services Growth Trends by Region
  15. 1.5.1 Global Peptide CRO Services Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Peptide CRO Services Market Size by Region (2021-2026)
  17. 1.5.3 Peptide CRO Services Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Peptide CRO Services Market Dynamics
  1. 2.1 Peptide CRO Services Industry Trends
  2. 2.2 Peptide CRO Services Industry Drivers
  3. 2.3 Peptide CRO Services Industry Opportunities and Challenges
  4. 2.4 Peptide CRO Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Peptide CRO Services Revenue by Company (2021-2026)
  2. 3.2 Global Peptide CRO Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Peptide CRO Services Key Company Head office and Area Served
  4. 3.4 Global Peptide CRO Services Company, Product Type & Application
  5. 3.5 Global Peptide CRO Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Peptide CRO Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Peptide CRO Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Peptide CRO Services Tier 1, Tier 2, and Tier 3
4 Peptide CRO Services Market by Type
  1. 4.1 Global Peptide CRO Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Peptide CRO Services Market Size by Type (2021-2032)
  3. 4.3 Global Peptide CRO Services Market Size Share by Type (2021-2032)
5 Peptide CRO Services Market by Application
  1. 5.1 Global Peptide CRO Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Peptide CRO Services Market Size by Application (2021-2032)
  3. 5.3 Global Peptide CRO Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 IMED Bioscience
  2. 6.1.1 IMED Bioscience Company Information
  3. 6.1.2 IMED Bioscience Business Overview
  4. 6.1.3 IMED Bioscience Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 IMED Bioscience Peptide CRO Services Product Portfolio
  6. 6.1.5 IMED Bioscience Recent Developments
  7. 6.2 Peptites Biotech
  8. 6.2.1 Peptites Biotech Company Information
  9. 6.2.2 Peptites Biotech Business Overview
  10. 6.2.3 Peptites Biotech Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Peptites Biotech Peptide CRO Services Product Portfolio
  12. 6.2.5 Peptites Biotech Recent Developments
  13. 6.3 Genevoyager
  14. 6.3.1 Genevoyager Company Information
  15. 6.3.2 Genevoyager Business Overview
  16. 6.3.3 Genevoyager Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Genevoyager Peptide CRO Services Product Portfolio
  18. 6.3.5 Genevoyager Recent Developments
  19. 6.4 Viva Biotech
  20. 6.4.1 Viva Biotech Company Information
  21. 6.4.2 Viva Biotech Business Overview
  22. 6.4.3 Viva Biotech Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Viva Biotech Peptide CRO Services Product Portfolio
  24. 6.4.5 Viva Biotech Recent Developments
  25. 6.5 Space Peptides Pharmaceutical
  26. 6.5.1 Space Peptides Pharmaceutical Company Information
  27. 6.5.2 Space Peptides Pharmaceutical Business Overview
  28. 6.5.3 Space Peptides Pharmaceutical Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Space Peptides Pharmaceutical Peptide CRO Services Product Portfolio
  30. 6.5.5 Space Peptides Pharmaceutical Recent Developments
  31. 6.6 Motif Biotechnology
  32. 6.6.1 Motif Biotechnology Company Information
  33. 6.6.2 Motif Biotechnology Business Overview
  34. 6.6.3 Motif Biotechnology Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Motif Biotechnology Peptide CRO Services Product Portfolio
  36. 6.6.5 Motif Biotechnology Recent Developments
  37. 6.7 JYMed Technology
  38. 6.7.1 JYMed Technology Company Information
  39. 6.7.2 JYMed Technology Business Overview
  40. 6.7.3 JYMed Technology Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 JYMed Technology Peptide CRO Services Product Portfolio
  42. 6.7.5 JYMed Technology Recent Developments
  43. 6.8 GenScript
  44. 6.8.1 GenScript Company Information
  45. 6.8.2 GenScript Business Overview
  46. 6.8.3 GenScript Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 GenScript Peptide CRO Services Product Portfolio
  48. 6.8.5 GenScript Recent Developments
  49. 6.9 TriApex Laboratories
  50. 6.9.1 TriApex Laboratories Company Information
  51. 6.9.2 TriApex Laboratories Business Overview
  52. 6.9.3 TriApex Laboratories Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 TriApex Laboratories Peptide CRO Services Product Portfolio
  54. 6.9.5 TriApex Laboratories Recent Developments
  55. 6.10 Go Top Peptide Biotech
  56. 6.10.1 Go Top Peptide Biotech Company Information
  57. 6.10.2 Go Top Peptide Biotech Business Overview
  58. 6.10.3 Go Top Peptide Biotech Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Go Top Peptide Biotech Peptide CRO Services Product Portfolio
  60. 6.10.5 Go Top Peptide Biotech Recent Developments
  61. 6.11 Sun-Novo Pharmaceutical Research
  62. 6.11.1 Sun-Novo Pharmaceutical Research Company Information
  63. 6.11.2 Sun-Novo Pharmaceutical Research Business Overview
  64. 6.11.3 Sun-Novo Pharmaceutical Research Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sun-Novo Pharmaceutical Research Peptide CRO Services Product Portfolio
  66. 6.11.5 Sun-Novo Pharmaceutical Research Recent Developments
  67. 6.12 Thermo Fisher
  68. 6.12.1 Thermo Fisher Company Information
  69. 6.12.2 Thermo Fisher Business Overview
  70. 6.12.3 Thermo Fisher Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Thermo Fisher Peptide CRO Services Product Portfolio
  72. 6.12.5 Thermo Fisher Recent Developments
  73. 6.13 Syngene
  74. 6.13.1 Syngene Company Information
  75. 6.13.2 Syngene Business Overview
  76. 6.13.3 Syngene Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Syngene Peptide CRO Services Product Portfolio
  78. 6.13.5 Syngene Recent Developments
  79. 6.14 Svar Life Science
  80. 6.14.1 Svar Life Science Company Information
  81. 6.14.2 Svar Life Science Business Overview
  82. 6.14.3 Svar Life Science Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Svar Life Science Peptide CRO Services Product Portfolio
  84. 6.14.5 Svar Life Science Recent Developments
  85. 6.15 PolyPeptide
  86. 6.15.1 PolyPeptide Company Information
  87. 6.15.2 PolyPeptide Business Overview
  88. 6.15.3 PolyPeptide Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 PolyPeptide Peptide CRO Services Product Portfolio
  90. 6.15.5 PolyPeptide Recent Developments
  91. 6.16 PeptiSystems
  92. 6.16.1 PeptiSystems Company Information
  93. 6.16.2 PeptiSystems Business Overview
  94. 6.16.3 PeptiSystems Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 PeptiSystems Peptide CRO Services Product Portfolio
  96. 6.16.5 PeptiSystems Recent Developments
  97. 6.17 Peptide Institute
  98. 6.17.1 Peptide Institute Company Information
  99. 6.17.2 Peptide Institute Business Overview
  100. 6.17.3 Peptide Institute Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Peptide Institute Peptide CRO Services Product Portfolio
  102. 6.17.5 Peptide Institute Recent Developments
  103. 6.18 Immunocure
  104. 6.18.1 Immunocure Company Information
  105. 6.18.2 Immunocure Business Overview
  106. 6.18.3 Immunocure Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Immunocure Peptide CRO Services Product Portfolio
  108. 6.18.5 Immunocure Recent Developments
  109. 6.19 Cusabio
  110. 6.19.1 Cusabio Company Information
  111. 6.19.2 Cusabio Business Overview
  112. 6.19.3 Cusabio Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Cusabio Peptide CRO Services Product Portfolio
  114. 6.19.5 Cusabio Recent Developments
  115. 6.20 CSBio
  116. 6.20.1 CSBio Company Information
  117. 6.20.2 CSBio Business Overview
  118. 6.20.3 CSBio Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 CSBio Peptide CRO Services Product Portfolio
  120. 6.20.5 CSBio Recent Developments
  121. 6.21 CPC Scientific
  122. 6.21.1 CPC Scientific Company Information
  123. 6.21.2 CPC Scientific Business Overview
  124. 6.21.3 CPC Scientific Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 CPC Scientific Peptide CRO Services Product Portfolio
  126. 6.21.5 CPC Scientific Recent Developments
  127. 6.22 Buchi
  128. 6.22.1 Buchi Company Information
  129. 6.22.2 Buchi Business Overview
  130. 6.22.3 Buchi Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Buchi Peptide CRO Services Product Portfolio
  132. 6.22.5 Buchi Recent Developments
  133. 6.23 Bachem AG
  134. 6.23.1 Bachem AG Company Information
  135. 6.23.2 Bachem AG Business Overview
  136. 6.23.3 Bachem AG Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Bachem AG Peptide CRO Services Product Portfolio
  138. 6.23.5 Bachem AG Recent Developments
  139. 6.24 Aurigene Pharmaceutical Services
  140. 6.24.1 Aurigene Pharmaceutical Services Company Information
  141. 6.24.2 Aurigene Pharmaceutical Services Business Overview
  142. 6.24.3 Aurigene Pharmaceutical Services Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Aurigene Pharmaceutical Services Peptide CRO Services Product Portfolio
  144. 6.24.5 Aurigene Pharmaceutical Services Recent Developments
  145. 6.25 AmbioPharm
  146. 6.25.1 AmbioPharm Company Information
  147. 6.25.2 AmbioPharm Business Overview
  148. 6.25.3 AmbioPharm Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 AmbioPharm Peptide CRO Services Product Portfolio
  150. 6.25.5 AmbioPharm Recent Developments
  151. 6.26 ABZENA PLC
  152. 6.26.1 ABZENA PLC Company Information
  153. 6.26.2 ABZENA PLC Business Overview
  154. 6.26.3 ABZENA PLC Peptide CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  155. 6.26.4 ABZENA PLC Peptide CRO Services Product Portfolio
  156. 6.26.5 ABZENA PLC Recent Developments
7 North America
  1. 7.1 North America Peptide CRO Services Market Size (2021-2032)
  2. 7.2 North America Peptide CRO Services Market Size by Type
  3. 7.2.1 North America Peptide CRO Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Peptide CRO Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Peptide CRO Services Market Share by Type (2021-2032)
  6. 7.3 North America Peptide CRO Services Market Size by Application
  7. 7.3.1 North America Peptide CRO Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Peptide CRO Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Peptide CRO Services Market Share by Application (2021-2032)
  10. 7.4 North America Peptide CRO Services Market Size by Country
  11. 7.4.1 North America Peptide CRO Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Peptide CRO Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Peptide CRO Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Peptide CRO Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Peptide CRO Services Market Size (2021-2032)
  2. 8.2 Europe Peptide CRO Services Market Size by Type
  3. 8.2.1 Europe Peptide CRO Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Peptide CRO Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Peptide CRO Services Market Share by Type (2021-2032)
  6. 8.3 Europe Peptide CRO Services Market Size by Application
  7. 8.3.1 Europe Peptide CRO Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Peptide CRO Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Peptide CRO Services Market Share by Application (2021-2032)
  10. 8.4 Europe Peptide CRO Services Market Size by Country
  11. 8.4.1 Europe Peptide CRO Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Peptide CRO Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Peptide CRO Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Peptide CRO Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Peptide CRO Services Market Size (2021-2032)
  2. 9.2 China Peptide CRO Services Market Size by Type
  3. 9.2.1 China Peptide CRO Services Market Size by Type (2021-2026)
  4. 9.2.2 China Peptide CRO Services Market Size by Type (2027-2032)
  5. 9.2.3 China Peptide CRO Services Market Share by Type (2021-2032)
  6. 9.3 China Peptide CRO Services Market Size by Application
  7. 9.3.1 China Peptide CRO Services Market Size by Application (2021-2026)
  8. 9.3.2 China Peptide CRO Services Market Size by Application (2027-2032)
  9. 9.3.3 China Peptide CRO Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Peptide CRO Services Market Size (2021-2032)
  2. 10.2 Asia Peptide CRO Services Market Size by Type
  3. 10.2.1 Asia Peptide CRO Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Peptide CRO Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Peptide CRO Services Market Share by Type (2021-2032)
  6. 10.3 Asia Peptide CRO Services Market Size by Application
  7. 10.3.1 Asia Peptide CRO Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Peptide CRO Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Peptide CRO Services Market Share by Application (2021-2032)
  10. 10.4 Asia Peptide CRO Services Market Size by Country
  11. 10.4.1 Asia Peptide CRO Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Peptide CRO Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Peptide CRO Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Peptide CRO Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Peptide CRO Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Peptide CRO Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Peptide CRO Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Peptide CRO Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Peptide CRO Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Peptide CRO Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Peptide CRO Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Peptide CRO Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Peptide CRO Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Peptide CRO Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Peptide CRO Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Peptide CRO Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Peptide CRO Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Peptide CRO Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research